Your browser doesn't support javascript.
loading
High-dosage ascorbic acid treatment in Charcot-Marie-Tooth disease type 1A: results of a randomized, double-masked, controlled trial.
Lewis, Richard A; McDermott, Michael P; Herrmann, David N; Hoke, Ahmet; Clawson, Lora L; Siskind, Carly; Feely, Shawna M E; Miller, Lindsey J; Barohn, Richard J; Smith, Patricia; Luebbe, Elizabeth; Wu, Xingyao; Shy, Michael E.
Affiliation
  • Lewis RA; Department of Neurology, Wayne State University, Detroit, Michigan, USA.
JAMA Neurol ; 70(8): 981-7, 2013 Aug.
Article in En | MEDLINE | ID: mdl-23797954
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ascorbic Acid / Charcot-Marie-Tooth Disease / Medical Futility / Antioxidants Type of study: Clinical_trials / Diagnostic_studies / Prognostic_studies Limits: Adolescent / Adult / Aged / Animals / Female / Humans / Male / Middle aged Language: En Journal: JAMA Neurol Year: 2013 Document type: Article Affiliation country: United States Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ascorbic Acid / Charcot-Marie-Tooth Disease / Medical Futility / Antioxidants Type of study: Clinical_trials / Diagnostic_studies / Prognostic_studies Limits: Adolescent / Adult / Aged / Animals / Female / Humans / Male / Middle aged Language: En Journal: JAMA Neurol Year: 2013 Document type: Article Affiliation country: United States Country of publication: United States